Health Technology Assessment (May 2005)

A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine

  • R Peveler,
  • T Kendrick,
  • M Buxton,
  • L Longworth,
  • D Baldwin,
  • M Moore,
  • J Chatwin,
  • J Goddard,
  • A Thornett,
  • H Smith,
  • M Campbell,
  • C Thompson

DOI
https://doi.org/10.3310/hta9160
Journal volume & issue
Vol. 9, no. 16

Abstract

Read online

No abstracts available.